Stefan Gebauer

Greiner Bio-One appoints new head of business for Preanalytics

Dr Stefan Gebauer has taken over management of the “Preanalytics” product division at Greiner Bio-One in Kremsmünster, Austria. He has many years of professional and management experience in the healthcare industry, focussing primarily on medical products in the IVD sector. Before joining Greiner Bio-One, he successfully managed the “Therapy Management” product line at Bosch Healthcare […]

agilent technologies logo

Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer

Agilent Technologies says its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in identifying cervical cancer patients for whom treatment with KEYTRUDA (pembrolizumab) may be appropriate. 

aptamer

Aptamer Group and PinotBio extend collaboration for the development of Optimer-drug conjugates

Aptamer Group, the developer of novel Optimer binders to enable innovation in the life sciences industry, has extended its collaboration agreement with PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, to develop four new Optimer-drug conjugates for use as precision chemotherapeutics. 

avacta scape space

Avacta establishes new Therapeutics HQ at Scale Space science cluster in London

Avacta Group, a clinical stage oncology drug company developing cancer therapies and diagnostics based on its proprietary pre|CISION and Affimer platforms, has relocated its Therapeutics division to a new headquarters at Scale Space, in Imperial College’s White City Campus, London.

Diasys

novabiomedical

quantimetrix

CAP

MWE

Altostar